Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Value Fund median (27 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 01 Apr 2017 – 20 Aug 2026, limited by Quantum Value Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Quantum Value Fund | Nifty 500 |
|---|---|---|
| 01 Apr 2017 | ₹100.00 | ₹100.00 |
| 12 Jan 2018 | ₹112.09 | ₹120.89 |
| 24 Oct 2018 | ₹104.40 | ₹107.01 |
| 06 Aug 2019 | ₹106.69 | ₹111.55 |
| 18 May 2020 | ₹78.64 | ₹90.62 |
| 27 Feb 2021 | ₹133.43 | ₹152.36 |
| 10 Dec 2021 | ₹156.91 | ₹189.55 |
| 22 Sep 2022 | ₹160.31 | ₹191.81 |
| 04 Jul 2023 | ₹177.09 | ₹207.08 |
| 15 Apr 2024 | ₹222.91 | ₹256.14 |
| 26 Jan 2025 | ₹246.01 | ₹266.65 |
| 07 Nov 2025 | ₹255.26 | ₹294.20 |
| 20 Aug 2026 | ₹244.13 | ₹294.09 |
| Metric | Quantum · Regular · IDCW NAV ₹119.33 Very High risk ★★★★☆ | Category median Value Fund · 27 funds |
|---|---|---|
| -5.29% | +1.55% | |
| +10.50% | +10.75% | |
| +9.98% | +10.54% | |
| — | +7.06% | |
| +9.98% | +8.32% | |
| +8.44% | — | |
| +13.53% | +10.45% | |
| +13.94% | +8.52% | |
| — | +6.67% | |
| Risk | ||
| 12.32% | 15.42% | |
| 0.33 | 0.30 | |
| 0.45 | 0.39 | |
| -40.30% | -47.99% | |
| Nifty 500 | — | |
| -0.52% | -0.99% | |
| 0.84 | 0.95 | |
| 81.8% | 99.4% | |
| 76.9% | 105.5% | |
| 2.17% | 2.35% | |
| ₹1,107Cr | ₹1,405Cr | |
| Up to 2.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹500 | — | |
| 4% | 40% | |
| Christy Mathai | — | |
| 01 Apr 2017 | — | |
| 31 | — | |
| 44.6% | — | |
| 6.6% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.